ESC 365 - Tocilizumab mitigates hypercoagulability after out-of-hospital cardiac arrest - results from a randomized controlled trial (IMICA)

Back

ESC Premium Access

Tocilizumab mitigates hypercoagulability after out-of-hospital cardiac arrest - results from a randomized controlled trial (IMICA)

Session: Frontiers in the diagnosis and management of cardiac arrest

Topic: Cardiac Arrest

Speaker: Doctor M. Meyer (Copenhagen, DK)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Martin Meyer

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

0 follower

4 more presentations in this session

Duration of resuscitation efforts and long-term prognosis following in-hospital cardiac arrest (IHCA)

Speaker: Mr H. Yonis (Hilleroed, DK)

Ischemic signs on the post-resuscitation ECG in absence of STEMI is associated with lower survival. A COACT trial's sub-study

Speaker: Mrs E. Spoormans (Amsterdam, NL)

Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a nationwide multicentre study

Speaker: Doctor S. Rasalingam Mork (Aarhus, DK)

Shortening pre-hospital time delay in patients with acute myocardial infarction using a modelling-based narrative intervention with a virtual heart attack experience: a randomized controlled trial

Speaker: Assistant Professor P. Li (Hong Kong, HK)

Access the full session

Frontiers in the diagnosis and management of cardiac arrest

Speakers: Doctor M. Meyer, Mr H. Yonis, Mrs E. Spoormans, Doctor S. Rasalingam Mork, Assistant Professor P. Li

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources